Recently, there has been much controversy over whether patients with prostate cancer should be treated with bisphosphonates not only to decrease pain, but to prevent metastasis.
ONCOLOGY Vol 14 No 9
Advertisement
Advertisement
Trending on CancerNetwork
1
Data Readouts to Watch at the 2026 ASCO Annual Meeting
2
Alpha DaRT Elicits 100% Local Disease Control in Pancreatic Cancer
3
Navigating The Dynamic Landscape of Stem Cell Transplantation
4
FDA OKs Updated Guardant360 Liquid CDx with Expanded Molecular Profiling
5